TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Prof. TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Special Professor, juntendo, Japan

Dr. Toshifumi Ohkusa is a highly regarded expert in gastroenterology and microbiota research, with a distinguished career spanning over four decades. He is currently a Special Professor at the Department of Microbiota Research at Juntendo University Graduate School of Medicine. Dr. Ohkusa has made significant contributions to the field of gastroenterology, particularly in understanding ulcerative colitis and intestinal microflora. 🌟👨‍⚕️

Publication profile

Scopus

 

Education

Dr. Ohkusa completed his medical degree (M.D.) from Tokyo Medical and Dental University in 1978. He pursued a Ph.D. from the same institution, where his groundbreaking research on ulcerative colitis in hamsters through dextran sulfate sodium and changes in intestinal microflora earned him a doctorate in 1986. 🎓📚

Experience

With an impressive academic journey, Dr. Ohkusa served as a Research Associate and Instructor at Tokyo Medical and Dental University from 1986 to 2001. He later joined Juntendo University, where he advanced from Assistant Professor to Associate Professor in the Department of Gastroenterology. Between 2008 and 2017, he held the prestigious position of Professor at The Jikei University Kashiwa Hospital. Currently, he leads microbiota research at Juntendo University. 💼🔬

Research Focus

Dr. Ohkusa’s research focuses on gastroenterology, particularly the mechanisms of ulcerative colitis and the role of intestinal microflora in gastrointestinal diseases. His work on microbiota research has significantly advanced the understanding of gastrointestinal health. 🔬🧫

Awards and Honors

Dr. Ohkusa has received numerous accolades for his groundbreaking work in gastroenterology and internal medicine, earning recognition from both Japanese and international medical societies. 🏆🌍

Publication Top Notes

Effect of probiotic bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: Results of a 24-week randomized, double-blind, placebo-controlled trial

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease

Correction: The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis (BMC Gastroenterology, (2022), 22, 1, (390), 10.1186/s12876-022-02474-9)

Wael El-Sayed | Microbiology | Best Research Article Award

Prof Dr. Wael El-Sayed | Microbiology | Best Research Article Award

Professor, Ain Shams University, Egypt

Dr. Wael M. El-Sayed is a distinguished Professor of Toxicology and Physiology with over 30 years of experience in research, education, and mentorship. He has made significant contributions to the fields of toxicology, drug development, and molecular biology, particularly in understanding the therapeutic mechanisms of natural products. His academic journey has taken him from Cairo to Salt Lake City, and his work continues to impact the global scientific community.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Experience:
    • Dr. El-Sayed has over 30 years of experience in physiology, toxicology, drug development, molecular biology, natural products, and tissue culture research. This extensive background demonstrates his deep knowledge and expertise in these fields.
  2. Diverse Research Interests:
    • His research spans a wide range of topics, including natural products, drug-drug interactions, chemoprotection strategies in cancer, antioxidants, and biochemical and molecular toxicology. This diversity reflects his ability to contribute to various research areas, which can be a significant advantage for a “Best Research Article Award.”
  3. High-Impact Publications:
    • Dr. El-Sayed has published research in reputable journals, such as Frontiers in Oncology and Journal of King Saud University – Science, which indicates the quality and relevance of his work. His recent studies on topics like the miRNome of hepatocellular carcinoma and potential COVID-19 inhibitors showcase his involvement in cutting-edge research.
  4. International Collaboration:
    • He has collaborated with researchers from different countries and institutions, including the University of Utah, USA, and King Faisal University, Saudi Arabia. This international exposure enriches his research perspectives and broadens the impact of his work.
  5. Recent and Relevant Publications:
    • The publication dates of his work, particularly in 2022 and 2023, indicate that Dr. El-Sayed is actively engaged in current research, which is crucial for winning an award for the best research article.

Areas for Improvement

  1. Focus on Breakthrough Research:
    • While Dr. El-Sayed’s research is diverse and impactful, the award committee might prioritize groundbreaking or highly innovative work. Emphasizing and furthering research that introduces novel concepts or significantly advances existing knowledge could strengthen his candidacy.
  2. Citation Impact and Recognition:
    • Although Dr. El-Sayed has published in high-quality journals, the impact of these publications, such as citation counts or recognition in the scientific community, could be further highlighted. Demonstrating the influence of his work on the field would reinforce his qualifications for the award.
  3. Enhanced Dissemination:
    • To increase the visibility and impact of his research, Dr. El-Sayed could focus on disseminating his findings through conferences, workshops, and broader media, enhancing the accessibility and application of his work beyond academic circles.

Education 🎓

Dr. El-Sayed earned his Ph.D. in Toxicology from Ain Shams University, Egypt, in collaboration with the College of Pharmacy, University of Utah, USA. His doctoral research focused on the “Mechanisms of therapeutic activities of Nigella Sativa against lipid peroxidation and hepatotoxicity in male albino rats.” Prior to this, he completed his M.Sc. in Physiology from Ain Shams University, where he explored the “Effect of Nigella Sativa on some physiological and biochemical parameters in male albino rats.” He also holds a B.Sc. in Science from Ain Shams University.

Experience 🧪

Dr. El-Sayed has held several key academic positions throughout his career. Since 2014, he has been a Professor at the Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt. He previously served as an Associate Professor at the same department (2009-2014) and at the Biology Department, King Faisal University, Saudi Arabia (2007-2013). His early academic career includes his role as an Assistant Professor at Ain Shams University (2003-2009).

Research Interests 🔬

Dr. El-Sayed’s research spans a broad spectrum of scientific domains, including:

  • Natural products: Investigating therapeutic properties from plant and animal sources.
  • Drug-drug interactions: Understanding how drugs interact and their metabolic pathways.
  • Novel drug evaluation: Assessing the efficacy and safety of new pharmaceuticals.
  • Cancer chemoprotection: Developing strategies for cancer prevention and treatment.
  • Antioxidants: Exploring their role in health and disease.
  • Molecular toxicology: Studying the biochemical and molecular effects of toxins.

Awards 🏆

Dr. El-Sayed’s dedication to scientific research and education has earned him recognition in the academic community. His innovative work in toxicology and natural products has positioned him as a leader in his field, contributing to numerous advancements that have been acknowledged by peers and institutions worldwide.

Publications Top Notes 📚

Dr. El-Sayed has authored numerous impactful publications. Some of his recent notable works include:

miRNome of Child A hepatocellular carcinoma in Egyptian patientsFrontiers in Oncology, 2023. DOI: 10.3389/fonc.2023.1137585
Cited by multiple studies exploring hepatocellular carcinoma.

1,4,9,9-tetramethyloctahydro-4,7-(epoxymethano)azulen-5(1H)-one, a natural product as a potential inhibitor of COVID-19Journal of King Saud University – Science, 2023. DOI: 10.1016/j.jksus.2023.102628
Referenced in research on antiviral drug development.

Investigating the Antifertility Efficacy of Testosterone on Male and Female Albino MicePakistan Journal of Zoology, 2023. DOI: 10.17582/journal.pjz/20211107091104
Contributed to studies on reproductive health.

New Benzochromeno[2,3-d]pyrimidines and Benzochromenotriazolo[1,5-c]pyrimidines as Potential Inhibitors of Topoisomerase IIPolycyclic Aromatic Compounds, 2022. DOI: 10.1080/10406638.2021.2006247
Cited in cancer research for topoisomerase inhibitors.

Conclusion

Dr. Wael M. El-Sayed is a highly qualified candidate for the “Best Research Article Award,” given his extensive experience, diverse research interests, and recent high-impact publications. His work contributes significantly to the fields of toxicology, drug development, and natural products, making him a strong contender. However, to maximize his chances, he may benefit from emphasizing the novelty and broader impact of his research, as well as enhancing its visibility within the scientific community. Overall, his credentials and contributions align well with the criteria for the award, making him a suitable candidate.

khadijeh dizajiasl | Microbiology Award | Outstanding Scientist Award

Assist Prof Dr khadijeh dizajiasl | Microbiology Award | Outstanding Scientist Award

Assist Prof Dr khadijeh dizajiasl, azad university of tabriz , Iran

 Khadijeh Dizaji Asl is an Assistant Professor at Azad University of Medical Sciences, Tabriz. Born on November 2, 1983, in Tabriz, Iran, she holds a B.Sc. in Radiology, an M.Sc., and a Ph.D. in Anatomical Sciences from Tabriz University of Medical Sciences. Her research focuses on NK cell therapy in leukemia and the impact of telomerase inhibition on cancer cells. Khadijeh has authored several impactful publications in renowned journals and has received recognition as an Outstanding PhD student. She is also noted for her teaching in anatomy and histology. 🧬

Publication Profile

Goolge scolar

Education

Khadijeh Dizaji Asl pursued a diverse academic journey at Tabriz University of Medical Sciences in Iran, beginning with a B.Sc. in Radiology from 2011 to 2013. She then continued her studies with an M.Sc. in Anatomical Sciences from 2014 to 2016, followed by a Ph.D. in the same field from 2016 to 2022. Her educational path reflects a deep commitment to advancing her expertise in medical sciences, particularly in anatomical research and its applications. Throughout her studies, Khadijeh has demonstrated a passion for knowledge and a dedication to contributing significantly to her field. 🎓

Experience: 💼

 📚 Khadijeh Dizaji Asl is a dedicated educator and researcher specializing in Anatomy and Histopathology. She began her teaching career at Tabriz University of Medical Sciences from 2019 to 2021, instructing courses in Gross Anatomy, Embryology, Histology for Midwives, Operating Room students, and Neuroanatomy for Dentistry students. Currently serving at Islamic Azad University, Tabriz branch, she continues to impart knowledge in Anatomy, Histology, and Embryology since 2021. Additionally, Khadijeh holds the roles of Assistant Professor and Head of the Anatomy and Histopathology Department at Islamic Azad University, Tabriz branch, where she shapes the future of medical education through her expertise and leadership. 🎓

Awards and Honors: 🏆

Khadijeh Dizaji Asl is a distinguished academic and researcher, recognized for her outstanding achievements in the field of anatomical sciences. She earned accolades such as being named the Outstanding PhD student in 2020 and the Educational Outstanding Student during her Master’s studies in 2016. Her contributions are further underscored by her paper being among the top downloads on Wiley. Currently an Assistant Professor and Head of the Anatomy and Histopathology Department at Islamic Azad University, Tabriz branch, Khadijeh continues to excel in both teaching and advancing scientific knowledge in her specialized field. 🧬

Research Focus

Khadijeh Dizaji Asl’s research primarily revolves around immunotherapy and cellular mechanisms in cancer treatment, focusing specifically on Natural Killer (NK) cells and their application in acute myeloid leukemia (AML), leukemia cell lines, and other malignancies. Her studies explore innovative approaches such as CAR-NK cell therapy and the effects of telomerase inhibition on NK cell activity. She investigates the role of KIR-positive NK cells in disease progression and therapeutic interventions. Additionally, Khadijeh explores the impact of NK cell dysfunction in infectious diseases like SARS-CoV-2. Her research aims to advance understanding and improve clinical outcomes through targeted immunotherapies. 🧬

Publications Top Notes

Therapeutic potential of neurotrophic factors in Alzheimer’s Disease Cited by 27, 2022 📖

Comparison of characteristics of human amniotic membrane and human adipose tissue derived mesenchymal stem cells Cited by 27, 2017 📖

Effect of aberrant DNA methylation on cancer stem cell properties Cited by 25, 2022 📖

The role of KIR positive NK cells in diseases and its importance in clinical intervention Cited by 24, 2021 📖

Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways Cited by 23, 2022 📖

Telomerase‐based therapies in haematological malignancies Cited by 9, 2022 📖

A combination of telomerase inhibition and NK cell therapy increased breast cancer cell line apoptosis Cited by 7, 2023 📖

The effect of telomerase inhibition on NK cell activity in acute myeloid leukemia Cited by 7, 2023 📖

NK cell dysfunction is linked with disease severity in SARS‐CoV‐2 patients Cited by 7, 2022 📖

Bone marrow CD34 positive cells may be suitable for collection after death Cited by 3, 2022 📖

Inhibition of mitochondria induces apoptosis and reduces telomere length and activity in acute myeloid leukemia stem cells